About Prothix

About company

Prothix focuses on protein biologics for inflammatory and coagulation disorders. Product leads, discovered by the company or licensed in from academia, are selected based on medical need, potential markets and customer needs and mee a so-called niche-buster profile, i.e. they will be developed for niche indications to obtain clinical proof of concept, while having blockbuster promise for other indications. Prothix will add value to these leads by executing preclinical proof of concept and early development studies. Prothix actively seeks cooperation or strategic alliances with academic groups and with companies to profile product candidates in a way that optimizes their commercial value.